Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Rating of “Hold” from Brokerages

Henry Schein, Inc. (NASDAQ:HSIC) has been assigned a consensus rating of “Hold” from the eleven ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $81.09.

Several equities analysts recently commented on HSIC shares. Jefferies Financial Group upped their price target on shares of Henry Schein from $74.00 to $81.00 and gave the company a “hold” rating in a research note on Wednesday, March 6th. SVB Leerink started coverage on shares of Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target on the stock. Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. Evercore ISI upped their price target on shares of Henry Schein from $79.00 to $83.00 and gave the company an “in-line” rating in a research note on Wednesday, February 28th. Finally, Piper Sandler upped their price target on shares of Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th.

Insiders Place Their Bets

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the sale, the insider now directly owns 209,562 shares in the company, valued at approximately $15,585,125.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The disclosure for this sale can be found here. Corporate insiders own 1.14% of the company’s stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently made changes to their positions in HSIC. Vanguard Group Inc. boosted its position in Henry Schein by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 15,331,533 shares of the company’s stock worth $1,336,756,000 after buying an additional 214,846 shares during the period. JPMorgan Chase & Co. boosted its position in Henry Schein by 1.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock worth $353,898,000 after buying an additional 53,506 shares during the period. American Century Companies Inc. boosted its position in Henry Schein by 7.3% during the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock worth $350,392,000 after buying an additional 322,649 shares during the period. Boston Partners boosted its position in Henry Schein by 144.1% during the 4th quarter. Boston Partners now owns 2,637,429 shares of the company’s stock worth $199,393,000 after buying an additional 1,556,831 shares during the period. Finally, Morgan Stanley boosted its position in Henry Schein by 143.4% during the 4th quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock worth $186,727,000 after buying an additional 1,377,207 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Price Performance

NASDAQ:HSIC opened at $70.73 on Thursday. Henry Schein has a one year low of $60.01 and a one year high of $85.39. The company has a market cap of $9.09 billion, a P/E ratio of 22.45, a P/E/G ratio of 1.76 and a beta of 0.87. The firm’s fifty day moving average price is $74.73 and its two-hundred day moving average price is $72.54. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.66 EPS for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a net margin of 3.37% and a return on equity of 14.03%. The company had revenue of $3.02 billion during the quarter, compared to analyst estimates of $3 billion. During the same quarter in the prior year, the firm earned $1.21 earnings per share. Henry Schein’s revenue for the quarter was down 10.5% on a year-over-year basis. Equities analysts expect that Henry Schein will post 5.07 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.